Syverson Strege & Co’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355K Sell
1,495
-47
-3% -$9.77K 0.08% 112
2026
Q1
$326K Buy
1,542
+99
+7% +$21.3K 0.08% 112
2025
Q4
$297K Buy
+1,443
New +$272K 0.07% 121
2023
Q2
Sell
-26
Closed -$1.96K 153
2023
Q1
$1.96K Buy
+26
New +$1.96K ﹤0.01% 493

Other funds holding CAH

Syverson Strege & Co's CAH Position: Q2 2026 in Review

Syverson Strege & Co reduced its Cardinal Health (CAH) stake by 3% in Q2 2026, selling an estimated $9.77K and leaving 1,495 shares worth $355K. The position accounts for 0.08% of the portfolio, ranked #112.

Syverson Strege & Co first reported a position in CAH in Q1 2023 and has held it in 4 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Syverson Strege & Co held 1,495 shares of Cardinal Health worth $355K as of Q2 2026.
  • Syverson Strege & Co sold 47 Cardinal Health shares in Q2 2026, an estimated $9.77K.
  • Cardinal Health made up 0.08% of Syverson Strege & Co's portfolio in Q2 2026, its #112 holding.
  • Syverson Strege & Co first reported a position in Cardinal Health in Q1 2023 and has held it in 4 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Syverson Strege & Co's 13F filing for Q2 2026, filed 6 Aug 2026.